1. Introduction
===============

Autism spectrum disorder (ASD) is one of the most common neurodevelopmental disorders. ASD usually appears in children by the age of 3 and is characterized by deficits in social interactions and communications and repetitive sensory-motor behaviors as well as stereotypic patterns of behaviors.^\[[@R1]\]^ ASD is a major pediatric health issue. According to the report from autism and developmental disabilities monitoring network, up to 3% of children in the US have ASD.^\[[@R2]\]^ ASD is associated with a range of high costs and families with autistic children are facing crushing economic burdens.^\[[@R3]\]^

Obesity and overweight are major public health issues, and the prevalence has been rising.^\[[@R4],[@R5]\]^ Obesity and overweight are the leading cause of death and are considered as one of the major causes of morbidity such as diabetes, cardiovascular disease, and cancer.^\[[@R6]--[@R8]\]^ Obesity and overweight in children can cause early death.^\[[@R9]\]^ Childhood obesity also presents an increased risk of adult obesity and is associated with health risks.^\[[@R10],[@R11]\]^ Obesity-related medical costs will rise to as high as \$48 billion to \$66 billion per year in the US and £1·9 to 2 billion per year in the UK by 2030.^\[[@R12]\]^ While the prevalence of underweight has not been rising,^\[[@R13]\]^ underweight among children and adolescents is associated with higher risk of various diseases and burdens of underweight is increasingly high in low- and middle-income countries.^\[[@R14]\]^

A growing number of studies have investigated the association between ASD and unhealthy weight status in children/adolescents and adults,^\[[@R15]--[@R17]\]^ while quiet variable results have been reported.^\[[@R18]--[@R20]\]^ Unlike underweight, the putative association between ASD and obesity/overweight might seem reasonable because, other than a disease, obesity, and overweight are often terms used to describe fatness and unhealthy dietary habit and lack of physical activities are recognized as the main drivers.^\[[@R21]\]^ It has been reported that individuals with ASD were less likely to participate in physical activities^\[[@R22]\]^ and ASD patients often have significantly dysregulated diet composition, with atypical selectivity (prefer more calorically dense foods).^\[[@R23]\]^ However, study results have not been consistent and to what extent are obesity and ASD are associated is not clear. More recently, high frequency of underweight class in children/adolescents with ASD has also been noted. Besides, the role of potential confounders in explaining the association has not been understood. Given the public health concerns of unhealthy weight status and ASD and the uncertainty about the association, it is of public health priority to assess the possible link and to evaluate the role of confounding factors on the relationship to design evidence-based prevention strategies.

The objective of this protocol is to conduct a systematic review and meta-analysis to estimate the global prevalence of obesity, overweight, and underweight in ASD based on existing literature. We specifically focus on whether, and to what extent, the prevalence of obesity, overweight, and underweight are significantly higher in individuals with ASD compared to those without. Also, possible confounding factors would be addressed by performing additional meta-analysis depending on data availability.

2. Methods
==========

Methods for performing this systematic review and meta-analysis have been defined in advance following recommendations from meta-analysis of observational studies in epidemiology statements^\[[@R24]\]^ and the preferred reporting items for systematic reviews and meta-analyses (PRISMA).^\[[@R25]\]^

2.1. Selection criteria
-----------------------

### 2.1.1. Study setting and population

All original, peer-reviewed studies that reporting data or estimates will be considered. We exclude case studies, reviews, meta-analysis, and meeting abstracts. Besides, to collect data as many as possible and summarize the global prevalence of obesity, overweight, and underweight in ASD, the control group setting is not a mandatory criterion for study inclusion. The representative populations will include children and/or adults with ASD. Study sample derived from the following sources will be considered:

1.  the general population;

2.  patients' registers and databases;

3.  screening programs;

4.  clinical settings.

No geographical limitations will be applied when selecting studies.

### 2.1.2. Definitions and outcome measures

The definition of ASD will include:

1.  categorical diagnosis according to the diagnostic and statistical manual of mental disorders or international classification of diseases;

2.  a validated ASD rating scales;

3.  records of medical system or registries of previous diagnosis of ASD;

4.  an affirmative answer from parents to the question "Did the doctor ever inform you that your kid has ASD?" about their children or from adults to the same question about themselves.

The definition of obesity/overweight will include:

1.  diagnosis report based on any of the internationally accepted body mass index cut-offs (Centers for Disease Control and Prevention,^\[[@R26]\]^ International Obesity Task Force,^\[[@R27]\]^ World Health Organization ^\[[@R28]\]^);

2.  records based on parental-report or self-report of obesity or overweight or directly measured data (height and weight).

2.2. Search strategy
--------------------

A series of complementary search method will be applied for the strategy. Relevant studies will be identified through searching the electronic databases: Pubmed, Embase, Cochrane Library, and ISI Web of Science. The search strategy was first developed in Pubmed using Mesh subject headings combined with keywords around the 2 search components (obesity, overweight and underweight and ASD). Then, the manual search will be conducted through reviewing reference lists or citations follow-up of identified eligible articles and relevant articles. No language limitation will be applied. Detailed search strategy for electronic databases is available in online supplementary Appendix 1.

2.3. Identification and selection of studies
--------------------------------------------

The records retrieved from electronic searches and manual searches will be grouped together and independently screened by 2 researchers for eligibility. Full-text copies would be obtained for records that potentially meet the eligibility. Then, these full-text articles will be independently assessed by 2 researchers for consideration of inclusion. Any disagreement about the eligibility will be resolved through consensus between the 2 researchers or discussion and a third author as arbitrator.

2.4. Data extraction
--------------------

The data in included studies will be independently extracted by 2 researchers. The following data will be extracted for all included studies using a standardized form: publication information (author, published year); study information (country where the study conducted, study setting, data source, study period); general population information (sample size, age, and gender distribution); specific population information (ASD criteria, treatment or medication use, comorbidities); outcome information (obesity, overweight and underweight definition, point prevalence rates of obesity, overweight and underweight for overall sample or for specific subgroups); confounding factors (if available). If studies did not report such point prevalence but provided the number of obese participants or height and weight information in ASD population, the data will be collected and calculated to obtain the prevalence rates. Any discrepancies for the data extraction will be resolved through consensus between the 2 authors or discussion with the third author as arbitrator.

2.5. Study quality assessment
-----------------------------

Two authors will independently assess the quality and bias in the included studies. Since there is no consensus on rating methods and appropriateness of quality assessment in systematic review and meta-analyses of observational studies. We will firstly use the Newcastle--Ottawa scale^\[[@R29]\]^ as recommended by the Cochrane collaboration, and then use the appraisal checklist proposed by the Joanna Briggs Institute,^\[[@R30]\]^ which is developed for studies reporting prevalence estimates and has been used in systematic review and meta-analysis. The results of 2 different rating systems will be referenced when performing sensitivity analysis and subgroup analysis. Any discrepancy in the rating of study quality and bias will be resolved by consensus between the 2 authors or through discussion with the third author as arbitrator.

2.6. Data analysis
------------------

We will first describe the characteristics of included studies in narrative text and baseline tables, and then perform meta-analysis to pool the prevalence of obesity/overweight in individuals with ASD. If available, meta-analysis of both crude and adjusted prevalence estimates will be conducted. Considering the variability between included studies, obesity/overweight prevalence pooled estimates and their 95% confidence intervals will be computed applying random-effects model of DerSimonian-Laird. Heterogeneity between studies will be assessed using the Cochran *Q* statistic and the *I*^2^ statistic.^\[[@R31]\]^*I*^2^ values of 25%, 50%, and 75% would be generally interpreted as low, medium and high heterogeneity, respectively. The presence of publication bias will be assessed by visually observing the funnel plot and by quantitative Egger^\[[@R32]\]^ and Begg^\[[@R33]\]^ tests. If publication bias is detected, the Duval Tweedie method will be used to obtain the adjusted estimates.^\[[@R34]\]^ Subgroup analysis and meta-regressions, depending on the data feasibility, would be performed considering the following covariates: study setting, gender, age, sample size, study period, geographical region, the method to assess ASD, the definition of obesity, overweight and underweight, comorbidities, medication use and quality of study. Also, sensitivity analysis will be performed to test the robustness of the pooled estimates. Statistical analyses will be performed in combination with Review Manager and Stata statistical software.

2.7. Presenting and reporting of results
----------------------------------------

The study selection process will be presented in a PRISMA flow chart (Fig. [1](#F1){ref-type="fig"}), and reasons for exclusion of studies will be provided. Data extracted from included studies will be summarized in baseline tables. The results of assessment of quality of study will be presented in tables showing scores in each domain. Raw data will be presented in baseline tables of individual studies, pooled estimates will be presented in forest plots and summary tables. Prevalence will be examined by subgroup analysis of variables described in Data analysis and presented in plots or tables where appropriate.

![Flow chart of the study selection process.](medi-98-e17274-g001){#F1}
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